Search

Your search keyword '"Supadmanaba, I. Gede Putu"' showing total 37 results
Start Over Author "Supadmanaba, I. Gede Putu"
37 results on '"Supadmanaba, I. Gede Putu"'

1. Exploring Splicing Modulation as an Innovative Approach to Combat Pancreatic Cancer: SF3B1 Emerges as a Prognostic Indicator and Therapeutic Target.

Author

Sciarrillo, Rocco, Terrana, Francesca, Comandatore, Annalisa, Supadmanaba, I. Gede Putu, Bing Wang, El Hassouni, Btissame, Mantini, Giulia, Jansen, Gerrit, Avan, Amir, Carbone, Daniela, Diana, Patrizia, Peters, Godefridus J., Morelli, Luca, Cloos, Jacqueline, Assaraf, Yehuda G., and Giovannetti, Elisa

Published
2024
Full Text
View/download PDF

21. The Risk of Antihypertensive Drug among Breast Cancer Patient: A Systematic Review and Meta-analysis

Author

Wiranata, Sinta, primary, Anjani, Ida Ayu Widya, additional, Wulandari, Putri Ayu, additional, Indrakusuma, Anak Agung Bagus Putra, additional, Sadeva, I Gede Krisna Arim, additional, Wisnawa, Ayu Dilia Febriani, additional, Fajar, Jonny Karunia, additional, Prabawa, I Putu Yuda, additional, Adiputra, Putu Anda Tusta, additional, Sudarsa, I Wayan, additional, Lestari, Anak Agung Wiradewi, additional, Wihandani, Desak Made, additional, and Supadmanaba, I Gede Putu, additional

Published
2021
Full Text
View/download PDF

31. The dichotomous role of the glycolytic metabolism pathway in cancer metastasis: Interplay with the complex tumor microenvironment and novel therapeutic strategies

Author

El Hassouni, Btissame, primary, Granchi, Carlotta, additional, Vallés-Martí, Andrea, additional, Supadmanaba, I Gede Putu, additional, Bononi, Giulia, additional, Tuccinardi, Tiziano, additional, Funel, Niccola, additional, Jimenez, Connie R., additional, Peters, Godefridus J., additional, Giovannetti, Elisa, additional, and Minutolo, Filippo, additional

Published
2020
Full Text
View/download PDF

37. Analysis of PD-L1 Expression in Breast Cancer: A Systematic Review and Meta-Analysis in Asian Population.

Author

Adiputra PAT, Sudarsa IW, Wihandani DM, Saputra IPGS, Wiranata S, and Supadmanaba IGP

Subjects
Female, Humans, B7-H1 Antigen metabolism, Prognosis, Proportional Hazards Models, Survival Analysis, Breast Neoplasms pathology
Abstract

Objective: This study aimed to investigate the level of PD-L1 protein expression in patients with BCs who were of Asian descent., Methods: Three databases were conducted on this article up to August 10th, 2022. The reference lists of the publications were examined for further studies, and in cases of duplicates, a study with a larger sample size was added. In survival analysis, the hazard ratio (HR) was applied to the circumstances characterized by the frequency of occurrences, and for the clinicopathological characteristic, the best-adjusted odds ratio (OR) with a 95% confidence interval (CI) was employed. The Newcastle-Ottawa Scale (NOS) was utilized to evaluate selection criteria, comparison, and exposure to establish the quality of the technique in the under-consideration studies. The Z test determined the association analysis of OS, DFS, and clinicopathological characteristics with PD-L1 expression., Result: All eight trials for OS and six for DFS were considered, with 4.111 and 3.071 participants, respectively. Overexpression of PD-L1 was linked to a reduced OS compared to individuals with undetectable expression (HR= 1.58, 95% CI 1.04-2.40; P=0.03). We analyzed clinicopathological features, and it elevated in individuals with histological grade III (OR=2.39, 95% CI 1.26-4.54; P=0.008) and positive node (OR=0.68, 95% CI 0.48-0.97; P<0.05)., Conclusion: Overexpression of PD-L1 was associated with a shorter OS in BCs patients. High PDL1 was higher in persons with nodal positivity and histological grade III.

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results